• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖、饮食干预与微生物群改变在前列腺癌发生发展中的作用

Obesity, dietary interventions and microbiome alterations in the development and progression of prostate cancer.

作者信息

Trecarten Shaun, Liss Michael A, Hamilton-Reeves Jill, DiGiovanni John

机构信息

Department of Urology, The University of Texas Health Sciences Center San Antonio, San Antonio, TX, United States.

Department of Urology, University of San Diego, San Diego, CA, United States.

出版信息

Front Immunol. 2025 Jan 7;15:1448116. doi: 10.3389/fimmu.2024.1448116. eCollection 2024.

DOI:10.3389/fimmu.2024.1448116
PMID:39840030
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11747771/
Abstract

PURPOSE OF REVIEW

The role of the microbiome in prostate cancer is an emerging subject of research interest. Certain lifestyle factors, such as obesity and diet, can also impact the microbiome, which has been implicated in many diseases, such as heart disease and diabetes. However, this link has yet to be explored in detail in the context of prostate cancer. The purpose of this review is to explore the cross-talk between obesity, dietary interventions, and microbiome alterations in the development and progression of prostate cancer.

RECENT FINDINGS

Many possible mechanisms exist linking obesity and dietary interventions to microbiome alterations and prostate cancer. The gut microbiome produces metabolites that could play a role in prostate cancer oncogenesis, including short-chain fatty acids, cholesterol derivatives, and folic acid. The microbiome also plays a pivotal role in the prostate tumor microenvironment (TME), contributing to inflammation, local tissue hypoxia, and epithelial-mesenchymal transition. A bidirectional relationship exists between obesity and the microbiome, and certain diets can enact changes to the microbiome, its associated metabolites, and prostate cancer outcomes.

SUMMARY

Cross-talk exists between obesity, dietary interventions, and the role of the microbiome in the development and progression of prostate cancer. To further our understanding, future human studies in prostate cancer should investigate microbiome changes and incorporate an assessment of microbiome-derived metabolites and cellular/immune changes in the TME.

摘要

综述目的

微生物群在前列腺癌中的作用是一个新兴的研究热点。某些生活方式因素,如肥胖和饮食,也会影响微生物群,而微生物群与许多疾病有关,如心脏病和糖尿病。然而,在前列腺癌的背景下,这种联系尚未得到详细探讨。本综述的目的是探讨肥胖、饮食干预与微生物群改变在前列腺癌发生发展过程中的相互作用。

最新研究发现

肥胖和饮食干预与微生物群改变及前列腺癌之间存在多种可能的联系机制。肠道微生物群产生的代谢产物可能在前列腺癌的肿瘤发生过程中发挥作用,包括短链脂肪酸、胆固醇衍生物和叶酸。微生物群在前列腺肿瘤微环境(TME)中也起着关键作用,促进炎症、局部组织缺氧和上皮-间质转化。肥胖与微生物群之间存在双向关系,某些饮食可以改变微生物群、其相关代谢产物以及前列腺癌的预后。

总结

肥胖、饮食干预与微生物群在前列腺癌发生发展过程中的作用之间存在相互作用。为了进一步加深我们的理解,未来关于前列腺癌的人体研究应调查微生物群的变化,并纳入对微生物群衍生代谢产物以及TME中细胞/免疫变化的评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69d6/11747771/9b3867098247/fimmu-15-1448116-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69d6/11747771/09c7d1b49df1/fimmu-15-1448116-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69d6/11747771/9b3867098247/fimmu-15-1448116-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69d6/11747771/09c7d1b49df1/fimmu-15-1448116-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69d6/11747771/9b3867098247/fimmu-15-1448116-g002.jpg

相似文献

1
Obesity, dietary interventions and microbiome alterations in the development and progression of prostate cancer.肥胖、饮食干预与微生物群改变在前列腺癌发生发展中的作用
Front Immunol. 2025 Jan 7;15:1448116. doi: 10.3389/fimmu.2024.1448116. eCollection 2024.
2
Dietary Changes Impact the Gut Microbe Composition in Overweight and Obese Men with Prostate Cancer Undergoing Radical Prostatectomy.饮食变化对接受根治性前列腺切除术的超重和肥胖前列腺癌男性肠道微生物组成的影响。
J Acad Nutr Diet. 2018 Apr;118(4):714-723.e1. doi: 10.1016/j.jand.2016.10.017. Epub 2016 Dec 15.
3
Diet and the microbiome as mediators of prostate cancer risk, progression, and therapy response.饮食与微生物群作为前列腺癌风险、进展及治疗反应的调节因素
Urol Oncol. 2025 Apr;43(4):209-220. doi: 10.1016/j.urolonc.2024.12.001. Epub 2025 Jan 4.
4
Gut microbiome and prostate cancer.肠道微生物组与前列腺癌。
Int J Urol. 2022 Aug;29(8):793-798. doi: 10.1111/iju.14894. Epub 2022 Apr 6.
5
Role of microbiome and its metabolite, short chain fatty acid in prostate cancer.微生物组及其代谢产物短链脂肪酸在前列腺癌中的作用。
Investig Clin Urol. 2023 Jan;64(1):3-12. doi: 10.4111/icu.20220370.
6
Role of Microbiota-Derived Metabolites in Prostate Cancer Inflammation and Progression.微生物群衍生代谢产物在前列腺癌炎症和进展中的作用
Cell Biochem Funct. 2025 Feb;43(2):e70050. doi: 10.1002/cbf.70050.
7
Dietary glycation compounds - implications for human health.饮食糖化化合物 - 对人类健康的影响。
Crit Rev Toxicol. 2024 Sep;54(8):485-617. doi: 10.1080/10408444.2024.2362985. Epub 2024 Aug 16.
8
Advances in human microbiome and prostate cancer research.人类微生物组与前列腺癌研究进展
Front Immunol. 2025 Apr 14;16:1576679. doi: 10.3389/fimmu.2025.1576679. eCollection 2025.
9
Specific Gut Microbial Environment in Lard Diet-Induced Prostate Cancer Development and Progression.猪油饮食诱导前列腺癌发生和发展的特定肠道微生物环境。
Int J Mol Sci. 2022 Feb 17;23(4):2214. doi: 10.3390/ijms23042214.
10
The role of the gut microbiome and its metabolites in metabolic diseases.肠道微生物组及其代谢产物在代谢性疾病中的作用。
Protein Cell. 2021 May;12(5):360-373. doi: 10.1007/s13238-020-00814-7. Epub 2020 Dec 21.

本文引用的文献

1
Phase 1 clinical trial evaluating safety, bioavailability, and gut microbiome with a combination of curcumin and ursolic acid in lipid enhanced capsules.评估脂质增强胶囊中姜黄素与熊果酸组合的安全性、生物利用度和肠道微生物群的1期临床试验。
J Tradit Complement Med. 2024 Mar 7;14(5):558-567. doi: 10.1016/j.jtcme.2024.03.002. eCollection 2024 Sep.
2
Nutritional Supplement With Fermented Soy in Men With an Elevated Risk of Prostate Cancer and Negative Prostate Biopsies: General and Oncological Results From the Prospective PRAECAP Trial.发酵大豆营养补充剂对前列腺癌风险升高和前列腺活检阴性男性的作用:前瞻性 PRAECAP 试验的一般和肿瘤学结果。
Urology. 2024 Jun;188:131-137. doi: 10.1016/j.urology.2024.04.028. Epub 2024 Apr 25.
3
The gut microbiome-prostate cancer crosstalk is modulated by dietary polyunsaturated long-chain fatty acids.
肠道微生物群与前列腺癌之间的相互作用受膳食多不饱和长链脂肪酸的调节。
Nat Commun. 2024 Apr 23;15(1):3431. doi: 10.1038/s41467-024-45332-w.
4
Current Trends and Challenges of Microbiome Research in Prostate Cancer.当前前列腺癌微生物组研究的趋势和挑战。
Curr Oncol Rep. 2024 May;26(5):477-487. doi: 10.1007/s11912-024-01520-x. Epub 2024 Apr 4.
5
Targeting the tumor microenvironment, a new therapeutic approach for prostate cancer.靶向肿瘤微环境,一种前列腺癌的新治疗方法。
Prostate Cancer Prostatic Dis. 2024 Apr 2. doi: 10.1038/s41391-024-00825-z.
6
A phase IIb randomized placebo-controlled trial testing the effect of MAG-EPA long-chain omega-3 fatty acid dietary supplement on prostate cancer proliferation.一项IIb期随机安慰剂对照试验,测试MAG-EPA长链omega-3脂肪酸膳食补充剂对前列腺癌增殖的影响。
Commun Med (Lond). 2024 Mar 22;4(1):56. doi: 10.1038/s43856-024-00456-4.
7
Mediterranean-style dietary interventions in adults with cancer: a systematic review of the methodological approaches, feasibility, and preliminary efficacy.地中海饮食干预在癌症成人患者中的应用:方法学方法、可行性和初步疗效的系统评价。
Eur J Clin Nutr. 2024 Jun;78(6):463-476. doi: 10.1038/s41430-024-01426-8. Epub 2024 Mar 8.
8
Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults.全球范围内 1990 年至 2022 年体重不足和肥胖趋势:对 3663 项具有 2.22 亿儿童、青少年和成年人代表性的人群研究进行的汇总分析。
Lancet. 2024 Mar 16;403(10431):1027-1050. doi: 10.1016/S0140-6736(23)02750-2. Epub 2024 Feb 29.
9
Preliminary study of the effect of gut microbiota on the development of prostatitis.肠道微生物群对前列腺炎发展影响的初步研究
BMC Med Genomics. 2024 Jan 25;17(1):35. doi: 10.1186/s12920-024-01812-y.
10
The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects.大豆异黄酮在前列腺癌治疗中的应用:关注细胞效应。
Nutrients. 2023 Nov 21;15(23):4856. doi: 10.3390/nu15234856.